FIGS Classe A FIGS, Inc. Class A Common Stock
NYSE · Textiles, Apparel & Luxury Goods · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 6, 2026FIGS Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
FIGS Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Sobre FIGS, Inc. Class A Common Stock Visão geral da empresa da Wikipedia
Figs (stylized as FIGS) is an American clothing company based in Santa Monica, California. The company sells scrubs and other products for healthcare professionals. It was founded in 2013 by Heather Hasson and Trina Spear, who are co-CEOs.
History
FIGS was founded by Heather Hasson and Trina Spear in Los Angeles, California in 2013. Hasson had the business idea when she realized that, unlike companies such as Lululemon, Under Armour, and Nike, that make clothes for athletes, there were no companies making fitted uniforms for health care professionals. Spear worked on Wall Street at the time and helped Hasson develop the business idea.
Hasson and Spear started FIGS using only their personal savings. They designed an alternative to the common scrubs available. Initially, they sold their product out of the parking lots of hospitals, getting feedback from staff. In 2013, Hasson and Spear raised a $2 million seed round so that they would not run out of product. In 2014 and 2015, they raised an additional $3 million. In 2016, the Lululemon-backed venture capital fund, Campfire, led the Series A funding round, which raised $5 million.
In 2017, Thomas Tull, businessman and founder of Legendary Pictures, invested $65 million in the company and became majority owner of FIGS. Others who have invested include Will Smith, Irving Place Capital, former Lululemon CEO Christine Day, and Mohr Davidow Ventures.
The company headquarters are in Santa Monica, California. In December 2015, FIGS was selected to join the Endeavor network, a startup accelerator and mentorship program. As of 2018 the company had raised a total of $75 million in funding. FIGS was recognized as one of the fastest-growing companies in the United States by Inc. in 2018, with the company having a three-year growth of 9,948%.
In 2019 FIGS opened a pop-up shop in Los Angeles. It added face masks to its products during the coronavirus pandemic in 2020, and expanded sales to Australia and the United Kingdom. In 2020, revenue doubled to $263 million and profits were almost $50 million.
In May 2021 FIGS filed for an initial public offering for $3 billion. On May 27, 2021, it became the first company led by two female cofounders to trade on the New York Stock Exchange. Also for the first time, FIGS allowed retail investors early access to purchase shares before the official sale began on the NYSE.
In November 2022, a California jury rejected all claims made by a competitor as "not valid" in a lawsuit alleging FIGS had "false advertising and misleading business practices." The lawsuit was concluded after almost 4 years of litigation.
By 2023, non-scrub products, including lab coats, activewear, loungewear, footwear, and compression socks, accounted for approximately 20% of the company's revenue.
Operation
FIGS sells scrubs, other medical clothing and associated products, including scrub tops, scrub pants, underscrubs, lab coats, activewear, and loungewear. The scrubs are made with a proprietary material that is antimicrobial for odor resistance with four-way stretch and pockets.
All sales are online, via the company's website. FIGS predicted revenue of over $250 million in 2020, mostly through the sale of its upgraded scrubs. The company's warehouse is in City of Industry, California.
Charitable operations
FIGS also operates the Threads for Threads program, which donates sets of scrubs to countries with limited access to medical apparel. The program includes giving trips and results in the donations of scrubs around the world. By 2019 the initiative had donated over 500,000 sets of scrubs in over 35 countries.
In the COVID-19 pandemic in early 2020, FIGS donated 30,000 sets of scrubs to New York hospitals Bellevue and Mount Sinai, and sent 100 care packages to health care workers every week. It contracted the production of over one million N95 masks and also donated them to hospitals and medical professionals.
Marketing
In October 2020, FIGS released a promotional video featuring a female osteopathic physician in neon pink scrubs reading a book titled "Medical Terminology for Dummies" while holding it upside down. The camera then cut to a zoomed in view of a blank badge labeled with the letters "DO". The video was taken down after widespread criticism as sexist, particularly from female physicians and osteopathic physicians.
Hasson and Spear apologized for the video and said they planned to hire consultants to help with future videos to avoid repeating this mistake. FIGS later partnered with the American Osteopathic Association and pledged $100,000 to it.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | FIGS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 41.0média 5A ≈5.8 | ≈5.8 | 18.9 | Sobreavaliado |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | FIGS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Bruta (TTM) | 68.9%média 5A ≈69.0% | ≈69.0% | 61.2% | Primeira linha | |
| Margem Operacional (TTM) | 9.6%média 5A ≈4.6% | ≈4.6% | 6.9% | Primeira linha | |
| Margem EBITDA (TTM) | 11.1%média 5A ≈5.3% | ≈5.3% | 8.0% | Primeira linha | |
| Margem de Impostos Pré-Tributação (TTM) | 10.8%média 5A ≈5.5% | ≈5.5% | 7.7% | Primeira linha | |
| Margem de Lucro Líquido (TTM) | 8.7%média 5A ≈2.4% | ≈2.4% | 5.8% | Primeira linha | |
| ROA (TTM) | 11.3%média 5A ≈2.8% | ≈2.8% | 3.6% | Primeira linha | |
| ROE (TTM) | 14.8%média 5A ≈3.6% | ≈3.6% | 9.3% | Em linha | |
| ROIC | 6.3%média 5A ≈2.8% | ≈2.8% | 7.1% | Em linha |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | FIGS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 5.0média 5A ≈5.1 | ≈5.1 | 2.1 | Liquidez forte | |
| Quick Ratio (Índice de Liquidez Seca) | 1.0média 5A ≈2.0 | ≈2.0 | 1.0 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | FIGS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 13.6%média 5A ≈20.7% | ≈20.7% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 7.6%média 5A ≈15.0% | ≈15.0% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 19.1% | · | · | · | |
| EPS YoY | 850.0%média 5A ≈258.6% | ≈258.6% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | 1159.2%média 5A ≈359.4% | ≈359.4% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 20.0% | · | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | -8.7% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 17.4% | · | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -7.2% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | FIGS | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 1.2média 5A ≈1.4 | ≈1.4 | 1.2 | Em linha | |
| Inventory Turnover (Giro de Estoque) | 1.7média 5A ≈1.5 | ≈1.5 | 2.5 | Fraco | |
| Receivables Turnover (Giro de Contas a Receber) | 105.3média 5A ≈100.8 | ≈100.8 | 9.0 | Primeira linha | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$1.9M | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 6, 2026 | $0.11 | $0.07 | 59.7% |
| 31 de Março de 2026 | $0.03 | $0.02 | 96.1% | |
| 31 de Dezembro de 2025 | $0.10 | $0.02 | 373.9% | |
| 30 de Setembro de 2025 | $0.05 | $0.02 | 170.3% | |
| 30 de Junho de 2025 | $0.04 | $0.02 | 106.2% | |
| 31 de Março de 2025 | $0.00 | $-0.00 | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $631M | $556M | $546M | $506M | $420M | $263M | $110M | |
| Cost of Revenue | $211M | $180M | $169M | $151M | $118M | $73M | $31M | |
| Gross Profit | $420M | $376M | $377M | $354M | $301M | $190M | $79M | |
| SG&A Expense | $143M | $143M | $141M | $121M | $150M | $42M | $22M | |
| Operating Expenses | $382M | $373M | $343M | $317M | $290M | $132M | $80M | |
| Operating Income | $38M | $2M | $34M | $38M | $11M | $58M | $-347.0K | |
| Other Non-op | $312.0K | $833.0K | $-13.0K | $-647.0K | $-885.0K | $0 | · | |
| Pretax Income | $47M | $14M | $41M | $39M | $10M | $58M | $112.0K | |
| Income Tax | $13M | $12M | $18M | $18M | $19M | $8M | $0 | |
| Net Income | $34M | $3M | $23M | $21M | $-10M | $50M | $112.0K | |
| EPS (Basic) | $0.21 | $0.02 | $0.13 | $0.13 | $-0.06 | $0.32 | $0.00 | |
| EPS (Diluted) | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 | $0.30 | $0.00 | |
| Shares (Basic) | 163,462,072 | 169,201,983 | 168,065,721 | 165,268,185 | 159,177,713 | 153,327,308 | 153,052,983 | |
| Shares (Diluted) | 179,486,886 | 180,102,840 | 182,412,965 | 187,547,474 | 159,177,713 | 163,331,348 | 153,624,013 | |
| EBITDA | $47M | $9M | $37M | $40M | $12M | · | · |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $82M | $86M | $144M | $160M | $195M | $58M | · | |
| Receivables | $5M | $7M | $7M | $6M | $2M | $6M | · | |
| Inventory | $128M | $116M | $119M | $178M | $86M | $50M | · | |
| Prepaid Expense | $12M | $13M | $12M | $12M | $7M | $7M | · | |
| Current Assets | $447M | $383M | $386M | $356M | $293M | $120M | · | |
| PP&E (Net) | $34M | $35M | $25M | $11M | $8M | $7M | · | |
| PP&E (Gross) | $56M | $48M | $33M | $16M | $10M | $8M | · | |
| Accum. Depreciation | $22M | $13M | $8M | $5M | $3M | $1M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $1M | $560.0K | $506.0K | · | |
| Total Assets | $580M | $510M | $473M | $395M | $312M | $134M | · | |
| Accounts Payable | $18M | $9M | $15M | $21M | $15M | $12M | · | |
| Accrued Liabilities | $21M | $42M | $8M | $26M | $25M | $7M | · | |
| Current Liabilities | $91M | $90M | $57M | $71M | $62M | $33M | · | |
| Capital Leases | $52M | $42M | $39M | $16M | $0 | · | · | |
| Other Non-current Liabilities | $182.0K | $83.0K | $183.0K | $176.0K | $243.0K | $0 | · | |
| Total Liabilities | $143M | $133M | $96M | $87M | $66M | $36M | · | |
| Common Stock | · | · | · | · | · | $15.0K | · | |
| Retained Earnings | $99M | $64M | $62M | $39M | $18M | $27M | · | |
| AOCI | $196.0K | $21.0K | $5.0K | $0 | · | · | · | |
| Stockholders' Equity | $437M | $377M | $377M | $308M | $246M | $98M | $39M | |
| Liabilities + Equity | $580M | $510M | $473M | $395M | $312M | $134M | · | |
| Shares Outstanding | · | · | · | · | 0 | 154,444,851 | · |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $3M | $2M | $1M | $946.0K | $500.0K | |
| Stock-based Comp | $27M | $43M | $46M | $37M | $81M | $9M | $179.0K | |
| Deferred Tax | $-544.0K | $7M | $-7M | $-732.0K | $-4M | $-7M | $0 | |
| Other Non-cash | $-8M | $22M | $37M | $-95M | $-3M | · | · | |
| Operating Cash Flow | $61M | $81M | $101M | $-35M | $66M | $22M | $7M | |
| CapEx | $8M | $17M | $16M | $5M | $3M | $2M | $5M | |
| Investing Cash Flow | $-64M | $-95M | $-117M | $-6M | $-3M | $-2M | $-5M | |
| Stock Issued | $0 | $250.0K | $0 | $0 | · | · | · | |
| Stock Repurchased | $3M | $45M | $0 | $0 | · | · | · | |
| Net Stock Activity | $-3M | $-45M | · | · | · | · | · | |
| Financing Cash Flow | $-969.0K | $-45M | $670.0K | $4M | $76M | $294.0K | $14M | |
| Net Change in Cash | $-4M | $-59M | $-16M | $-38M | $139M | $20M | $16M | |
| Taxes Paid | $8M | $13M | $21M | $12M | $15M | $18M | $0 | |
| Free Cash Flow | $53M | $64M | $85M | $-41M | $64M | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% | · | · | |
| Operating Margin | 6.0% | 0.41% | 6.2% | 7.4% | 2.6% | · | · | |
| Net Margin | 5.4% | 0.49% | 4.2% | 4.2% | -2.3% | · | · | |
| Pretax Margin | 7.5% | 2.6% | 7.5% | 7.7% | 2.4% | · | · | |
| EBITDA Margin | 7.5% | 1.6% | 6.8% | 7.8% | 2.9% | · | · | |
| ROA | 6.3% | 0.55% | 5.2% | 6.0% | -4.3% | · | · | |
| ROE | 8.2% | 0.70% | 6.2% | 7.1% | -4.1% | · | · | |
| ROIC | 6.3% | 0.11% | 5.0% | 6.7% | -4.3% | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 4.2 | 6.7 | 5.0 | 4.7 | · | · | |
| Quick Ratio | 1.0 | 1.0 | 2.6 | 2.3 | 3.2 | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.1 | 1.3 | 1.4 | 1.9 | · | · | |
| Inventory Turnover | 1.7 | 1.5 | 1.1 | 1.1 | 1.7 | · | · | |
| Receivables Turnover | 105.3 | 84.3 | 85.0 | 127.4 | 102.1 | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $3.52 | $3.08 | $2.99 | $2.70 | $2.64 | · | · | |
| Cash Flow / Share | $0.34 | $0.45 | $0.55 | $-0.19 | $0.42 | · | · | |
| EPS (TTM) | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 | · | · |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 1.8% | 7.9% | 20.5% | 59.5% | · | · | |
| Revenue CAGR 3Y | 7.6% | 9.8% | 27.5% | · | · | · | · | |
| Revenue CAGR 5Y | 19.1% | · | · | · | · | · | · | |
| EPS YoY | 850.0% | -83.3% | 9.1% | · | · | · | · | |
| EPS CAGR 3Y | 20.0% | · | -26.3% | · | · | · | · | |
| EPS CAGR 5Y | -8.7% | · | · | · | · | · | · | |
| Net Income YoY | 1159.2% | -88.0% | 6.9% | · | · | · | · | |
| Net Income CAGR 3Y | 17.4% | · | -23.1% | · | · | · | · | |
| Net Income CAGR 5Y | -7.2% | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $631M | $556M | $546M | $506M | $420M | · | · | |
| Net Income TTM | $34M | $3M | $23M | $21M | $-10M | · | · | |
| Market Cap | · | · | · | · | $0 | · | · | |
| P/E | 59.8 | 309.5 | 57.9 | 61.2 | -459.3 | · | · | |
| P/S | · | · | · | · | 0.0 | · | · | |
| P / Tangible Book | · | · | · | · | 0.0 | · | · | |
| P / Cash Flow | · | · | · | · | 0.0 | · | · | |
| P / FCF | · | · | · | · | 0.0 | · | · | |
| Earnings Yield | 1.7% | 0.32% | 1.7% | 1.6% | -0.22% | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $197M | $160M | $202M | $152M | $153M | $125M | $152M | $140M | $144M | $119M | $145M | $142M | $138M | $120M | $145M | $129M | |
| Cost of Revenue | $49M | $52M | $75M | $46M | $50M | $40M | $50M | $46M | $47M | $37M | $47M | $45M | $42M | $35M | $46M | $38M | |
| Gross Profit | $148M | $108M | $127M | $106M | $102M | $84M | $102M | $94M | $97M | $82M | $98M | $97M | $96M | $86M | $99M | $91M | |
| SG&A Expense | $40M | $38M | $37M | $37M | $35M | $34M | $36M | $36M | $36M | $36M | $35M | $36M | $35M | $34M | $37M | $28M | |
| Operating Expenses | $113M | $104M | $108M | $96M | $92M | $85M | $93M | $103M | $96M | $82M | $84M | $87M | $89M | $82M | $96M | $80M | |
| Operating Income | $35M | $4M | $19M | $10M | $10M | $-211.0K | $9M | $-9M | $2M | $443.0K | $14M | $10M | $7M | $3M | $3M | $11M | |
| Other Non-op | $-526.0K | $-277.0K | $307.0K | $9.0K | $-3.0K | $-1.0K | $841.0K | $2.0K | $0 | $-10.0K | $-2.0K | $-6.0K | $-4.0K | $-1.0K | $-647.0K | $1.0K | |
| Pretax Income | $37M | $6M | $21M | $12M | $12M | $2M | $12M | $-6M | $4M | $3M | $17M | $12M | $8M | $4M | $4M | $12M | |
| Income Tax | $9M | $157.0K | $3M | $3M | $5M | $2M | $10M | $-4M | $3M | $2M | $7M | $6M | $4M | $2M | $247.0K | $8M | |
| Net Income | $28M | $6M | $19M | $9M | $7M | $-102.0K | $2M | $-2M | $1M | $1M | $10M | $6M | $5M | $2M | $3M | $4M | |
| EPS (Basic) | $0.17 | $0.04 | $0.12 | $0.05 | $0.04 | $0.00 | $0.01 | $-0.01 | $0.01 | $0.01 | $0.05 | $0.04 | $0.03 | $0.01 | $0.03 | $0.02 | |
| EPS (Diluted) | $0.15 | $0.03 | $0.10 | $0.05 | $0.04 | $0.00 | $0.01 | $-0.01 | $0.01 | $0.01 | $0.06 | $0.03 | $0.02 | $0.01 | $0.01 | $0.02 | |
| Shares (Basic) | 166,467,633 | 166,460,085 | · | 163,665,566 | 162,683,329 | 162,465,988 | · | 170,168,732 | 170,393,480 | 169,923,479 | · | 168,668,844 | 167,423,656 | 166,773,335 | · | 165,543,067 | |
| Shares (Diluted) | 195,139,642 | 196,090,295 | · | 180,875,933 | 172,929,960 | 162,465,988 | · | 170,168,732 | 179,688,524 | 180,701,844 | · | 181,429,745 | 183,332,560 | 182,853,746 | · | 186,991,769 | |
| EBITDA | $35M | $8M | · | $10M | $10M | $2M | · | $-9M | $2M | $1M | · | $10M | $7M | $4M | · | $11M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $109M | $74M | $82M | $46M | $51M | $90M | $86M | $124M | $132M | $155M | · | $183M | $147M | $156M | · | $156M | |
| Receivables | $7M | $4M | $5M | $11M | $8M | $5M | $7M | $9M | $12M | $5M | · | $6M | $6M | $3M | · | $3M | |
| Inventory | $120M | $139M | $128M | $151M | $136M | $132M | $116M | $123M | $119M | $130M | · | $143M | $168M | $180M | · | $168M | |
| Prepaid Expense | $14M | $11M | $12M | $13M | $10M | $10M | $13M | $19M | $17M | $11M | · | $13M | $10M | $10M | · | $14M | |
| Current Assets | $453M | $432M | $447M | $418M | $394M | $400M | $383M | $434M | $417M | $406M | · | $395M | $369M | $350M | · | $346M | |
| PP&E (Net) | $33M | $33M | $34M | $34M | $33M | $34M | $35M | $35M | $35M | $28M | · | $16M | $11M | $11M | · | $11M | |
| PP&E (Gross) | $61M | $58M | $56M | $53M | $50M | $49M | $48M | $46M | $45M | $37M | · | $23M | $18M | $17M | · | $15M | |
| Accum. Depreciation | $28M | $25M | $22M | $19M | $17M | $15M | $13M | $11M | $10M | $9M | · | $7M | $6M | $5M | · | $4M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $583M | $563M | $580M | $545M | $517M | $522M | $510M | $542M | $526M | $511M | · | $442M | $411M | $388M | · | $386M | |
| Accounts Payable | $9M | $8M | $18M | $5M | $19M | $11M | $9M | $27M | $20M | $22M | · | $15M | $12M | $9M | · | $21M | |
| Accrued Liabilities | $40M | $36M | $21M | $34M | $22M | $54M | $42M | $29M | $22M | $17M | · | $16M | $18M | $21M | · | $32M | |
| Current Liabilities | $91M | $80M | $91M | $87M | $78M | $101M | $90M | $95M | $77M | $72M | · | $70M | $57M | $53M | · | $76M | |
| Capital Leases | $49M | $52M | $52M | $45M | $42M | $40M | $42M | $44M | $48M | $49M | · | $16M | $17M | $15M | · | $17M | |
| Other Non-current Liabilities | $264.0K | $263.0K | $182.0K | $83.0K | $83.0K | $83.0K | $83.0K | $183.0K | $183.0K | $183.0K | · | $176.0K | $176.0K | $176.0K | · | $215.0K | |
| Total Liabilities | $140M | $133M | $143M | $131M | $121M | $141M | $133M | $139M | $124M | $121M | · | $87M | $74M | $68M | · | $93M | |
| Retained Earnings | $133M | $105M | $99M | $80M | $71M | $64M | $64M | $63M | $64M | $63M | · | $52M | $46M | $41M | · | $36M | |
| AOCI | $-240.0K | $-103.0K | $196.0K | $162.0K | $70.0K | $-24.0K | $21.0K | $221.0K | $-47.0K | $-26.0K | · | $-4.0K | $-8.0K | · | · | · | |
| Stockholders' Equity | $442M | $431M | $437M | $413M | $397M | $382M | $377M | $404M | $402M | $390M | $377M | $355M | $337M | $320M | $308M | $292M | |
| Liabilities + Equity | $583M | $563M | $580M | $545M | $517M | $522M | $510M | $542M | $526M | $511M | · | $442M | $411M | $388M | · | $386M |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $1M | $850.0K | $814.0K | $756.0K | $713.0K | $659.0K | $637.0K | $479.0K | |
| Stock-based Comp | $7M | $5M | $5M | $7M | $8M | $7M | $10M | $11M | $10M | $12M | $11M | $12M | $12M | $11M | $11M | $9M | |
| Deferred Tax | $6.0K | $6.0K | $911.0K | $-2M | $-893.0K | $995.0K | $6M | $-2M | $2M | $251.0K | $-5M | $-857.0K | $-544.0K | $-440.0K | $244.0K | $-661.0K | |
| Other Non-cash | · | $-18M | · | · | · | $-896.0K | · | · | · | $-3M | · | · | · | $-16M | · | · | |
| Operating Cash Flow | $47M | $-3M | $61M | $3M | $-12M | $9M | $30M | $23M | $17M | $12M | $20M | $54M | $29M | $-3M | $5M | $-13M | |
| CapEx | $3M | $2M | $3M | $3M | $1M | $1M | $3M | $4M | $9M | $496.0K | $7M | $8M | $841.0K | $772.0K | $1M | $3M | |
| Investing Cash Flow | $11M | $14M | $-26M | $-9M | $-27M | $-2M | $-31M | $-23M | $-40M | $-474.0K | $-59M | $-18M | $-39M | $-772.0K | $-1M | $-3M | |
| Stock Repurchased | $24M | $9M | $0 | $0 | $0 | $3M | $38M | $7M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-9M | · | · | · | $-3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-23M | $-18M | $401.0K | $1M | $185.0K | $-3M | $-38M | $-7M | $254.0K | $10.0K | $153.0K | $126.0K | $636.0K | $-245.0K | $733.0K | $1M | |
| Net Change in Cash | $34M | $-8M | $36M | $-4M | $-39M | $4M | $-38M | $-8M | $-24M | $11M | $-39M | $36M | $-9M | $-4M | $4M | $-15M | |
| Free Cash Flow | · | $-6M | · | · | · | $8M | · | · | · | $11M | · | · | · | $-4M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 75.2% | 67.7% | · | 69.9% | 67.0% | 67.6% | · | 67.1% | 67.4% | 68.8% | · | 68.4% | 69.5% | 71.3% | · | 70.6% | |
| Operating Margin | 17.9% | 2.8% | · | 6.3% | 6.5% | -0.17% | · | -6.2% | 1.1% | 0.37% | · | 7.0% | 4.8% | 2.7% | · | 8.7% | |
| Net Margin | 14.4% | 3.9% | · | 5.8% | 4.7% | -0.08% | · | -1.2% | 0.76% | 1.2% | · | 4.3% | 3.3% | 1.6% | · | 3.1% | |
| Pretax Margin | 18.8% | 4.0% | · | 7.9% | 7.9% | 1.5% | · | -4.1% | 3.0% | 2.8% | · | 8.3% | 5.9% | 3.6% | · | 9.2% | |
| EBITDA Margin | 17.9% | 4.9% | · | 6.3% | 6.5% | 1.4% | · | -6.2% | 1.1% | 1.1% | · | 7.0% | 4.8% | 3.3% | · | 8.7% | |
| ROA | 5.2% | 1.2% | · | 1.6% | 1.4% | -0.02% | · | -0.35% | 0.23% | 0.32% | · | 1.5% | 1.2% | 0.52% | · | 1.2% | |
| ROE | 6.8% | 1.6% | · | 2.1% | 1.8% | -0.03% | · | -0.45% | 0.30% | 0.40% | · | 1.9% | 1.5% | 0.65% | · | 1.6% | |
| ROIC | 6.1% | 1.0% | · | 1.7% | 1.5% | 0.00% | · | -0.64% | 0.10% | 0.05% | · | 1.5% | 1.1% | 0.45% | · | 1.3% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.4 | · | 4.8 | 5.0 | 4.0 | · | 4.6 | 5.4 | 5.6 | · | 5.6 | 6.5 | 6.6 | · | 4.5 | |
| Quick Ratio | 1.3 | 1.0 | · | 0.7 | 0.8 | 0.9 | · | 1.4 | 1.9 | 2.2 | · | 2.7 | 2.7 | 3.0 | · | 2.1 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.4 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 26.8 | 34.3 | · | 15.2 | 15.6 | 24.3 | · | 19.4 | 16.7 | 29.5 | · | 34.0 | 27.8 | 39.9 | · | 34.3 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $1.01 | $0.82 | · | $0.84 | $0.88 | $0.77 | · | $0.82 | $0.80 | $0.66 | · | $0.78 | $0.75 | $0.66 | · | $0.69 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $0.06 | · | · | · | $0.06 | · | · | · | $-0.02 | · | · | |
| EPS (TTM) | $0.33 | $0.22 | · | $0.10 | $0.04 | $0.01 | · | $0.07 | $0.11 | $0.12 | · | $0.07 | $0.06 | $0.07 | · | $0.20 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $710M | $666M | · | $581M | $570M | $561M | · | $549M | $551M | $545M | · | $546M | $532M | $516M | · | $490M | |
| Net Income TTM | $62M | $41M | · | $18M | $7M | $1M | · | $11M | $19M | $22M | · | $16M | $14M | $14M | · | $30M | |
| P/E | 31.0 | 67.1 | · | 66.9 | 141.0 | 459.0 | · | 97.7 | 48.5 | 41.5 | · | 84.3 | 137.8 | 88.4 | · | 41.2 | |
| Earnings Yield | 3.2% | 1.5% | · | 1.5% | 0.71% | 0.22% | · | 1.0% | 2.1% | 2.4% | · | 1.2% | 0.73% | 1.1% | · | 2.4% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $631M | $556M | $546M | $506M | $420M |
| Margem Bruta % | 66.5% | 67.6% | 69.1% | 70.1% | 71.8% |
| Margem Operacional % | 6.0% | 0.41% | 6.2% | 7.4% | 2.6% |
| Lucro líquido | $34M | $3M | $23M | $21M | $-10M |
| EPS Diluído | $0.19 | $0.02 | $0.12 | $0.11 | $-0.06 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 4.9 | 4.2 | 6.7 | 5.0 | 4.7 |
| Índice de Liquidez Seca | 1.0 | 1.0 | 2.6 | 2.3 | 3.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $53M | $64M | $85M | $-41M | $64M |
Investidores institucionais (13F) 261 declarantes · $1.7B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 48 (-16 vs trimestre anterior) | 44 (+24 vs trimestre anterior) | 91 (+6 vs trimestre anterior) | 73 (+8 vs trimestre anterior) | +7.9M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| BAMCO INC /NY/ | $613.385.163 | 59.959.449 | 35,59% | Ações |
| VANGUARD GROUP INC | $109.164.158 | 9.609.521 | 6,33% | Ações |
| BlackRock, Inc. | $87.395.229 | 8.543.033 | 5,07% | Ações |
| Driehaus Capital Management LLC | $52.799.465 | 5.161.238 | 3,06% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $47.786.110 | 4.671.174 | 2,77% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $44.938.896 | 4.392.854 | 2,61% | Ações |
| MARSHALL WACE, LLP | $44.354.193 | 4.335.698 | 2,57% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $38.250.727 | 3.739.074 | 2,22% | Ações |
| GOLDMAN SACHS GROUP INC | $37.747.165 | 3.689.850 | 2,19% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $37.264.048 | 3.641.706 | 2,16% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $36.514.827 | 3.568.384 | 2,12% | Ações |
| Divisadero Street Capital Management, LP | $32.644.196 | 3.191.026 | 1,89% | Ações |
| STATE STREET CORP | $27.017.614 | 2.641.018 | 1,57% | Ações |
| TWO SIGMA INVESTMENTS, LP | $24.874.429 | 2.431.518 | 1,44% | Ações |
| FULLER & THALER ASSET MANAGEMENT, INC. | $21.646.913 | 2.116.023 | 1,26% | Ações |
| JANE STREET GROUP, LLC | $21.222.105 | 2.074.497 | 1,23% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $20.588.591 | 2.012.570 | 1,19% | Ações |
| AMERIPRISE FINANCIAL INC | $19.667.133 | 1.922.496 | 1,14% | Ações |
| Nuveen, LLC | $19.330.046 | 1.889.545 | 1,12% | Ações |
| CITADEL ADVISORS LLC | $18.466.225 | 1.805.105 | 1,07% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $17.166.963 | 1.678.100 | 1,00% | Ações |
| JENNISON ASSOCIATES LLC | $15.300.726 | 1.495.672 | 0,89% | Ações |
| Woodline Partners LP | $14.577.873 | 1.425.012 | 0,85% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $12.303.908 | 1.202.728 | 0,71% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.951.167 | 1.168.247 | 0,69% | Ações |
| MACKENZIE FINANCIAL CORP | $11.718.127 | 1.145.467 | 0,68% | Ações |
| Black Creek Investment Management Inc. | $11.049.812 | 1.080.138 | 0,64% | Ações |
| MORGAN STANLEY | $10.919.254 | 1.067.375 | 0,63% | Ações |
| NORTHERN TRUST CORP | $10.630.587 | 1.039.158 | 0,62% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $10.428.431 | 1.019.397 | 0,61% | Ações |
| JPMORGAN CHASE & CO | $10.119.531 | 909.482 | 0,59% | Ações |
| Balyasny Asset Management L.P. | $9.858.150 | 963.651 | 0,57% | Ações |
| Qube Research & Technologies Ltd | $9.400.899 | 918.954 | 0,55% | Ações |
| FIRST TRUST ADVISORS LP | $7.709.859 | 753.652 | 0,45% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.272.507 | 710.900 | 0,42% | Opção de compra |
| Applied Fundamental Research, LLC | $7.132.837 | 697.247 | 0,41% | Ações |
| FMR LLC | $6.806.788 | 665.375 | 0,39% | Ações |
| TWO SIGMA ADVISERS, LP | $6.297.984 | 554.400 | 0,37% | Ações |
| UBS Group AG | $6.263.532 | 612.271 | 0,36% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $5.980.192 | 584.574 | 0,35% | Ações |
| TUDOR INVESTMENT CORP ET AL | $5.862.680 | 573.087 | 0,34% | Ações |
| Hillsdale Investment Management Inc. | $5.134.539 | 501.910 | 0,30% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4.831.915 | 472.328 | 0,28% | Ações |
| RICE HALL JAMES & ASSOCIATES, LLC | $4.204.653 | 411.012 | 0,24% | Ações |
| D. E. Shaw & Co., Inc. | $4.196.581 | 410.223 | 0,24% | Ações |
| BANK OF AMERICA CORP /DE/ | $3.877.977 | 379.079 | 0,23% | Ações |
| Susquehanna Portfolio Strategies, LLC | $3.614.597 | 353.333 | 0,21% | Ações |
| Malaga Cove Capital, LLC | $3.492.164 | 341.365 | 0,20% | Ações |
| ALGERT GLOBAL LLC | $3.484.573 | 340.623 | 0,20% | Ações |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $3.360.892 | 328.533 | 0,20% | Ações |
Ativistas e proprietários de 5%+ 6 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Hasson Heather L. ×3 declarações | 12 de Maio de 2026 | 8,40% | Emenda | · | SEC |
| Spear Catherine Eva ×3 declarações | 12 de Maio de 2026 | 15,00% | Emenda | · | SEC |
| BAMCO INC /NY/, Baron Capital Management, Inc, Ronald Baron, Baron Capital Group, Inc, Baron Growth Fund, Baron Focused Growth Fund ×7 declarações | 3 de Março de 2026 | 37,93% | Emenda | · | SEC |
| Thomas J. Tull ×5 declarações | 21 de Fevereiro de 2025 | 0,00% | Emenda | · | SEC |
| Catherine Spear ×8 declarações | 28 de Agosto de 2024 | · | Declaração inicial | · | SEC |
| Heather Hasson ×8 declarações | 28 de Agosto de 2024 | · | Declaração inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 18 insiders · 5 diretores · 12 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Catherine Eva Spear | Chief Executive Officer | 1 de Julho de 2026 F | 1.733.408 | 0 | 3 | $-1.894.115 |
| Sarah Oughtred | Chief Financial Officer | 5 de Agosto de 2026 F | 1.088.165 | 0 | 6 | $-1.097.115 |
| Kevin Fosty | Former Interim CFO | 7 de Agosto de 2024 S | 65.536 | 0 | 0 | $0 |
| Daniella Turenshine | Chief Financial Officer | 5 de Março de 2024 S | 409.858 | 0 | 0 | $0 |
| Hasson Heather L. | Executive Chairman | 5 de Agosto de 2026 F | 1.396.852 | 0 | 4 | $-10.252.337 |
| Hsiao Yueh Jao | Conselheiro | 3 de Junho de 2026 A | 97.719 | 0 | 0 | $0 |
| Kenneth Jian-Hong Lin | Conselheiro | 3 de Junho de 2026 A | 161.705 | 0 | 0 | $0 |
| John Martin Willhite | Conselheiro | 3 de Junho de 2026 A | 3.263.095 | 0 | 0 | $0 |
| Sheila Antrum | Conselheiro | 3 de Junho de 2026 A | 115.663 | 0 | 0 | $0 |
| Melanie Anya Whelan | Conselheiro | 3 de Junho de 2026 A | 55.683 | 0 | 0 | $0 |
| Mario Jesus Marte | Conselheiro | 3 de Junho de 2026 A | 86.046 | 0 | 0 | $0 |
| Jeffrey A Wilke | Conselheiro | 3 de Junho de 2026 A | 227.577 | 0 | 0 | $0 |
| Alan G Lafley | Conselheiro | 17 de Dezembro de 2024 G | 141.165 | 0 | 0 | $0 |
| Michael J Soenen | Conselheiro | 7 de Junho de 2023 A | 52.652 | 0 | 0 | $0 |
| Christopher Peter Varelas | Conselheiro | 1 de Junho de 2021 P | 52.274 | 0 | 0 | $0 |
| BAMCO INC /NY/ | Detentor de 10% | 20 de Fevereiro de 2025 C | 27.833.825 | 0 | 0 | $0 |
| Thomas J. Tull | Detentor de 10% | 11 de Janeiro de 2025 X | 6.675.631 | 0 | 0 | $0 |
| Tulco, LLC | Detentor de 10% | 21 de Março de 2022 C | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 36 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| PEZ · Invesco Exchange-Traded Fund Trust | 3,05% | 46.890 SH | 2 de Outubro de 2026 | Diário |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,28% | 343.129 NS | 31 de Julho de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 234.929 SH | 19 de Agosto de 2026 | Diário |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 15.299 SH | 2 de Outubro de 2026 | Diário |
| IWO · iShares Trust | 0,08% | 893.638 SH | 11 de Setembro de 2026 | Diário |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 85.273 NS | 31 de Julho de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 102.017 SH | 19 de Agosto de 2026 | Diário |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 31.082 NS | 31 de Julho de 2026 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0,06% | 88.497 NS | 31 de Julho de 2026 | N-PORT |
| VCR · VANGUARD WORLD FUND | 0,05% | 355.298 SH | 19 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 80.276 SH | 2 de Outubro de 2026 | Diário |
| EBIT · Harbor ETF Trust | 0,04% | 471 NS | 31 de Julho de 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 2.429.839 SH | 11 de Setembro de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,04% | 521.429 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 26.052 SH | 11 de Setembro de 2026 | Diário |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 22.416 NS | 31 de Julho de 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 45.466 NS | 31 de Julho de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 547.697 SH | 19 de Agosto de 2026 | Diário |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.821.842 SH | 19 de Agosto de 2026 | Diário |
| VBK · VANGUARD INDEX FUNDS | 0,02% | 1.148.655 SH | 19 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,01% | 5.743 SH | 11 de Setembro de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,01% | 1.997.017 SH | 19 de Agosto de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,01% | 390.844 NS | 31 de Julho de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 17.756 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 11.938 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 8.908 NS | 31 de Julho de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 59.278 NS | 31 de Julho de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 36.685 NS | 31 de Julho de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 223.355 SH | 11 de Setembro de 2026 | Diário |
| DFUS · Dimensional ETF Trust | 0,00% | 34.315 NS | 31 de Julho de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23.946 SH | 11 de Setembro de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,00% | 88 NS | 31 de Julho de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.758.703 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.241 SH | 19 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | · | 3.675 SH | 11 de Setembro de 2026 | Diário |
| SMLF · iShares Trust | · | 35.184 SH | 11 de Setembro de 2026 | Diário |
FIGS Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
Preço-alvo de 12 meses
8 analistas · 2026-09-29Alvo médio $18.62 +37,8%
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| FIGS | · | 59.8 | 13.6% | 5.4% | 8.2% | 66.5% |
| LEVI | $8.60B | 15.2 | 4.1% | 9.2% | 26.5% | 61.7% |
| VFC | $6.42B | 25.6 | 1.1% | 2.6% | 15.3% | · |
| PVH | · | 119.9 | 3.4% | 0.28% | 0.52% | 57.5% |
| KTB | $3.40B | 15.2 | 20.9% | 7.2% | 42.8% | · |
| COLM | · | 17.0 | 0.85% | 5.2% | 10.5% | 50.5% |
| UAA | · | -5.1 | -3.8% | -10.0% | -30.3% | 45.5% |
| GIII | · | 19.0 | -7.0% | 2.3% | 3.9% | 39.4% |
| CRI | $1.21B | 13.1 | 1.9% | 3.2% | 10.3% | 45.4% |
| MOV | · | 19.5 | 2.7% | 4.0% | 5.4% | 54.2% |
| FOSL | · | -2.6 | -12.3% | · | · | · |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.